Quince Therapeutics Overview
Contact top employees from
Quince Therapeutics
Summary
Quince Therapeutics is a public company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the Chairman & CEO is occupied by Casey C. Lynch. Its headquarters is located at South San Francisco, California, USA. The number of employees ranges from 25 to 100. The Quince Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $308.1M. To connect with Quince Therapeutics employee register on SignalHire.
Quince Therapeutics industries
Biotechnology
Headquarters Location
Quince Therapeutics Employees Size
10-50 employees
Specialties
Alzheimer's, neuroscience, neurodegenerative disease, Alzheimer's disease
SIC Code
2836, 2834
DMA Code
San Francisco Bay Area
Founded
2012
Operating Status
Independent Company
Quince Therapeutics Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2013 | Public Company | 100 - 250 | 24.6M | $407.5M | |
| 2013 | Privately Held | 25 - 100 | 8M | $94.3M | |
| 2001 | Privately Held | 25 - 100 | 7M | $208.4M | |
| 2015 | Public Company | 250 - 500 | 357.1M | $597M | |
| 2017 | Privately Held | 1 - 25 | 3M | $40M | |
| 1998 | Public Company | 1 - 25 | < 1M | $203.8M | |
| 2015 | Privately Held | 25 - 100 | 6M | $36M | |
| - | - | 100-200 | - | $- |
Quince Therapeutics Funding
By Q1 2020, Quince Therapeutics has participated in at least 6 funding rounds and has raised a minimum of 308.1M. Funding increased noticeable in Q1 2020 — by 50.0M compared to the previous Q2 2019. Quince Therapeutics raised the least in Q2 2014 at 1.0M, while the most successful funding round in Q1 2020 raised 125.0M.
Quince Therapeutics Employees Turnover 2 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Ex-employees positions
In Company
In New Company
Contact top employees from
Quince Therapeutics
Mostafa Hossam
Associate Director of SEC Reporting and Consolidation
Sandy Leng
Executive Director, Controller
Dina Cooper
Sr Accountant
Kevin Wall
Senior Director Technical Operations
Kristen Gafric
SVP Legal & Administration & Officer
Christina Griffin
Research Associate
Mary Ellen Sillivos
Vice President, Human Resources
Merrill Biel
Executive Medical Director
Brendan Hannah
Chief Operating Officer & Chief Business Officer
Annie Quilatan
Senior Executive Assistant
Brent Roeck
Vice President, Program and Alliance Management
Shae Danis
Associate Director, Finance and Accounting
Willy Ting
Senior GL Accountant
Caralee Schaefer
Vice President, Nonclinical Development
Stacy Roughan
Vice President, Corporate Communications & Investor Relations
Charles Ryan
President
Company Employee
Chief Technology Officer
Company Employee
Clinical Study Manager
Company Employee
Coordinatore risorse umane
